A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics
Clinical trial NCT05970978 · COMPLETED
Trial details
- NCT number
- NCT05970978
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-28
- Primary completion
- 2024-07-19
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.